Wakix 4.45 mg Oral Tablet
RxNorm 2197890
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2197890 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Wakix 4.45 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Pitolisant 4.45 mg Oral Tablet [Wakix]
(Atom ID: 11444798)
SYPrescribable
Synonym (SY):
Wakix 4.45 mg (as pitolisant HCl 5 mg) Oral Tablet
(Atom ID: 11444801)
PSNPrescribable
Prescribable Name (PSN):
Wakix 4.45 mg Oral Tablet
(Atom ID: 11444799)
SYPrescribable
Synonym (SY):
Wakix 4.45 mg Oral Tablet
(Atom ID: 11444800)
Patient Education
Pitolisant
Pitolisant is used to treat excessive daytime sleepiness caused by narcolepsy (a condition that causes excessive daytime sleepiness) and to treat cataplexy (episodes of muscle weakness that begin suddenly and last for a short time) in adults with narcolepsy. Pitolisant is in a class of medications called H3 blockers. It works by changing the amounts of certain natural substances in the area of the brain that controls sleep and wakefulness.
[Learn More]
* Please review the disclaimer below.